Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-05-30 Purchase | 2023-05-31 08:32 am | XWELL Inc. | XWEL | WEINSTEIN ROBERT Director | 25,000 | $0.247 | $6,175 | 156,485 (Direct) | View |
2023-05-26 Purchase | 2023-05-30 08:34 am | XWELL Inc. | XWEL | WEINSTEIN ROBERT Director | 25,000 | $0.25 | $6,250 | 131,485 (Direct) | View |
2022-12-16 Sale | 2022-12-20 8:02 pm | Synaptogenix Inc. | SNPX | WEINSTEIN ROBERT Chief Financial Officer | 27,000 | $1.1719 | $31,641 | 33,198 (Direct) | View |
2022-04-20 Sale | 2022-04-22 7:59 pm | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 45,000 | $1.06 | $47,700 | 106,485 (Direct) | View |
2022-01-19 Sale | 2022-01-21 5:08 pm | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 45,000 | $1.5608 | $70,236 | 120,235 (Direct) | View |
2021-09-20 Sale | 2021-10-22 4:15 pm | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 63,000 | $1.4319 | $90,210 | 165,235 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-15 Option Award | 2024-11-18 6:37 pm | N/A 2034-11-15 | XWELL Inc. | XWEL | WEINSTEIN ROBERT Director | 30,825 | $0 | 30,825 (Direct) | View |
2024-04-30 Option Award | 2024-07-17 4:59 pm | N/A 2034-04-30 | PharmaCyte Biotech Inc. | PMCB | WEINSTEIN ROBERT Director | 38,009 | $0 | 38,009 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:02 pm | 2023-11-20 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | WEINSTEIN ROBERT Director | 61,248 | $0 | 61,248 (Direct) | View |
2023-01-05 Option Award(A) | 2023-01-09 9:37 pm | N/A 2033-01-05 | XWELL Inc. | XWEL | WEINSTEIN ROBERT Director | 300,000 | $0 | 300,000 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 3:00 pm | N/A 2033-01-05 | XWELL Inc. | XWEL | WEINSTEIN ROBERT Director | 300,000 | $0 | 300,000 (Direct) | View |
2022-11-15 Option Award(A) | 2022-12-01 7:54 pm | N/A 2032-11-15 | Synaptogenix Inc. | SNPX | WEINSTEIN ROBERT Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2022-11-15 Option Award | 2022-11-17 4:02 pm | N/A 2032-11-15 | Synaptogenix Inc. | SNPX | WEINSTEIN ROBERT Chief Financial Officer | 96,000 | $0 | 96,000 (Direct) | View |
2022-01-26 Option Award | 2022-01-31 8:19 pm | N/A 2032-01-26 | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 78,125 | $0 | 243,360 (Direct) | View |
2021-07-29 Option Award | 2021-07-30 5:22 pm | N/A N/A | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 200,000 | $0 | 228,235 (Direct) | View |
2021-07-13 Option Award | 2021-07-15 6:06 pm | N/A N/A | Synaptogenix Inc. | SNPX | WEINSTEIN ROBERT Chief Financial Officer | 60,000 | $0 | 60,198 (Direct) | View |
Ownership | 2021-06-14 8:16 pm | N/A N/A | Synaptogenix Inc. | WEINSTEIN ROBERT Chief Financial Officer | 0 | $0 | 11,389 (Direct) | View | |
2021-01-04 Option Award | 2021-01-06 4:35 pm | N/A 2031-01-04 | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 71,312 | $0 | 71,312 (Direct) | View |
2020-12-01 Disposition | 2020-12-03 9:40 pm | N/A N/A | Neurotrope Inc. | NTRP | WEINSTEIN ROBERT See Remarks | 215,407 | $0 | 0 (Direct) | View |
2020-11-24 Option Award | 2020-11-27 5:07 pm | N/A 2030-11-24 | Neurotrope Inc. | NTRP | WEINSTEIN ROBERT See Remarks | 135,000 | $0 | 135,000 (Direct) | View |
2020-04-20 Option Award | 2020-04-21 7:58 pm | N/A 2030-04-20 | XpresSpa Group Inc. | XSPA | WEINSTEIN ROBERT Director | 185,000 | $0 | 185,000 (Direct) | View |